CymaBay Therapeutics Banner Image

CymaBay Therapeutics

  • Ticker CBAY
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
CymaBay Therapeutics Logo Image
  • 11-50 Employees
  • Based in Newark, California
CymaBay Therapeutics, Inc. (CBAY) is a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, including serious rare and orphan disorders. MBX-8025 is a potent, selective, orally active PPARδ agonist.
4.8 / 5.0 (118)

CymaBay Therapeutics reports have an aggregate usefulness score of 4.8 based on 118 reviews.

CymaBay Therapeutics

Most Recent Annual Report

CymaBay Therapeutics
MOST RECENT 2022 Annual Report and Form 10K

CymaBay Therapeutics does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

CymaBay Therapeutics Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!